Inovio Pharmaceuticals Inc. Stock Slides 16.9%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. tumbled 16.9% to $0.77 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.4% to 26,184.72 and Dow Jones Industrial Average falling 0.3% to 52,342.56.

The stock's fall snapped a two-day winning streak.

Inovio Pharmaceuticals Inc. closed 71.6% below its 52-week high of $2.72, which the company achieved on December 17th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.5% to $275.20, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.70% to $29.95.

Trading volume totaled 9.5 million, compared to the 50-day average of 3.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 29, 2026 16:33 ET (20:33 GMT)